The Gross Margin of Kyongbo Pharmaceutical Co Ltd (214390.KS) is 34.55%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 34.55% |
| 2023-12-31 | 29.15% |
| 2022-12-31 | 22.63% |
| 2021-12-31 | 20.72% |
| 2020-12-31 | 24.37% |
| 2019-12-31 | 21.24% |
| 2018-12-31 | 24.47% |
| 2017-12-31 | 28.50% |
| 2016-12-31 | 23.62% |
| 2015-12-31 | 27.27% |